Mexico Research Antibodies Market Size & Outlook
Mexico research antibodies market, 2018-2030 (US$M)
Related Markets
Mexico research antibodies market highlights
- The Mexico research antibodies market generated a revenue of USD 21.2 million in 2023 and is expected to reach USD 29.7 million by 2030.
- The Mexico market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, primary was the largest revenue generating product in 2023.
- Primary is the most lucrative product segment registering the fastest growth during the forecast period.
Research antibodies market data book summary
| Market revenue in 2023 | USD 21.2 million |
| Market revenue in 2030 | USD 29.7 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Primary |
| Fastest growing segment | Primary |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Primary, Secondary |
| Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
Other key industry trends
- In terms of revenue, Mexico accounted for 1.3% of the global research antibodies market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil research antibodies market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 29.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research Antibodies Market Scope
Research Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico research antibodies market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research antibodies market will help companies and investors design strategic landscapes.
Primary was the largest segment with a revenue share of 75% in 2023. Horizon Databook has segmented the Mexico research antibodies market based on primary, secondary covering the revenue growth of each sub-segment from 2018 to 2030.
The Mexico research antibodies market is expected to showcase high CAGR during the forecast period owing to rising healthcare spending by people, growing opportunities for biologics manufacturers, and increasing medical tourism in this region. Mexico has been a popular destination for U.S. and Canada citizens pursuing treatment at minimum cost.
Proximity to the U.S. and lower travel costs have been attracting Canadians and Americans to Mexico for various treatments including stem cell therapy. Baja Orthopedics, Hospital Angeles, and International Bio Care Hospital are some of the private hospitals in Mexico that provide stem cell therapy for various chronic conditions.
Thus, patients from developed countries such as U.S., Germany, UK, and other European countries are expected to travel to Mexico for the treatment of diseases such as diabetes, Alzheimer's, Parkinson's, multiple sclerosis, heart disease, and blood cancer.
Reasons to subscribe to Mexico research antibodies market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico research antibodies market databook
-
Our clientele includes a mix of research antibodies market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico research antibodies market , including forecasts for subscribers. This country databook contains high-level insights into Mexico research antibodies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico research antibodies market size, by product, 2018-2030 (US$M)
Mexico Research Antibodies Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
